Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q3V6T2 (
ape
)
2,133
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Vascular permeability is regulated by intercellular junction organization of endothelial cells, the dysfunction of which is implicated in numerous pathological conditions. Molecular mechanisms of how endothelial cells regulate intercellular junction in response to extracellular signals, however, have so far remained elusive. This study identified that
Girdin
(also termed
GIV
), an Akt substrate functioning in post natal angiogenesis, was expressed in a mature endothelial monolayer, where it regulated
VE-cadherin
trafficking to maintain vascular integrity.
Girdin
depletion abrogated VEGF-induced
VE-cadherin
endocytosis and the disassembly of adherens junctions in a monolayer of endothelial cells, thus leading to a significant decrease in the permeability. We also showed that activated R-Ras, a member of the Ras family GTPase, known to be a master regulator of transendothelial permeability, interacts with
Girdin
, and facilitates the complex formation between
Girdin
and
VE-cadherin
in endothelial cells. However, the increased permeability mediated by the loss of R-Ras was rescued by
Girdin
depletion, thus suggesting that the interaction of
Girdin
with R-Ras functions in
VE-cadherin
trafficking pathways distinct from endocytosis. The recycling of
VE-cadherin
was promoted by the exogenous expression of the active mutant of R-Ras, which was attenuated in the
Girdin
-depleted endothelial cells. These results show that
Girdin
regulates transendothelial permeability in synergy with R-Ras and
VE-cadherin
in an endothelial monolayer.
...
PMID:Girdin/GIV regulates transendothelial permeability by controlling VE-cadherin trafficking through the small GTPase, R-Ras. 2586 66